Role of Homoeopathic medicine in reducing melasma in women

THE EFFECTIVENESS OF INDIVIDUALIZED HOMOEOPATHIC MEDICINE IN THE MANAGEMENT OF MELASMA IN WOMEN A QUASI EXPERIMENTAL STUDY - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/089538

Enrollment

Registered

2025-06-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

Intervention1: Individualized Homoeopathic Medicines: After enrollment the case will be repertorised Appropriate potentized Individualised Homoeopathic Medicine will be administered in minimum dose in

Eligibility

Inclusion criteria

Inclusion criteria: Women in age group 18-60 years of age Patients with signs or clinical diagnosis of melasma

Exclusion criteria

Exclusion criteria: Patients who are currently on Oral contraceptives or Hormone replacement therapy Pregnant or lactating mothers Women during their first year of childbirth Patients with any other hyperpigmentation disorder Patients with any other terminal systemic illness

Design outcomes

Primary

Measure	Time frame
Reduction in mMASI score after individualized homoeopathic medicineTimepoint: At baseline and every 3rd month	—

Secondary

Measure	Time frame
Reduction in MELASQOL score after individualized homoeopathic medicineTimepoint: At baseline and every 3rd month	—

Countries

India

Contacts

Public ContactDrPDastagiri

National Homoeopathy Research Institute In Mental Health

drdastagirinhrimh@gmail.com9000444409

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026